Clinical trial
Randomised Phase II Pilot Studiy: Induction Chemotherapy with Docetaxel, Cisplatin und Cetuximab versus Docetaxel, Cisplatin und 5 FU followed by Radiotherapy with Cetuximab for locally advanced or not resectable Carcinoma of the Head and Neck
Response Rate (CR, PR) 3 months after end of therapy (RECIST)
| Category | Value |
|---|---|
| Study start date | 2013-01-22 |